Roxithromycin Reduces Cyclosporine-Induced Gingival Hyperplasia in Renal Transplant Patients

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1435-1438

  Conde S A P ^a   Aarestrup, F M ^a   Vieira, B J ^a   Bastos, M G ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Department of Nefrology   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; AZATHIOPRINE; CYCLOSPORIN A; LOSARTAN; NIFEDIPINE; PREDNISONE; ROXITHROMYCIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; EXTRACELLULAR MATRIX; FEMALE; GINGIVA HYPERPLASIA; GINGIVA OVERGROWTH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AZATHIOPRINE; CYCLOSPORINE; FEMALE; GINGIVAL HYPERPLASIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; ROXITHROMYCIN;

EID: 45749095808     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.04.012     Document Type: Article

References (18)

1. Kahan B.D. Cyclosporine. N Engl J Med 321 (1989) 1725
2. Yoshida T., Nagata J., and Yamane A. Growth factors and proliferation of cultured rat gingival cells in response to cyclosporin A. J Periodontal Res 40 (2005) 11
3. Saito K., Mori S., Iwakura M., et al. Immunohistochemical localization of transforming growth factor b, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontal Res 31 (1996) 545
4. Barnard J.A., Lyons R.M., and Moses H.L. The cell biology of trasnsforming growth factor-β. Biochim Biophys Acta 1032 (1990) 79
5. Gómez E., Sánchez-Nuñes M., Sánchez J.E., et al. Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 12 (1997) 2694
6. Citterio F., DI Pinto M.T., Borzi M.C., et al. Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe. Transplant Proc 33 (2001) 2134
7. Tokgoz B., Sari H.I., Yildiz O., et al. Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients. Transplant Proc 36 (2004) 2699
8. Yamabe H., Shimada M., Kaizuka M., et al. Roxithromycin inhibits transforming growth factor-β production by cultured human mesangial cells. Nephrology 11 (2006) 524
9. Wondimu B., Nemeth A., and Modeer T. Oral health in liver transplant children administered cyclosporin A or tacrolimus. Int J Paediatr Dent 11 (2001) 424
10. Newell J., and Irwin C.R. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 68 (1997) 443
11. Spratt H., Boomer S., Irwin C.R., et al. Cyclosporine associated gingival overgrowth in renal transplant recipients. Oral Dis 5 (1999) 27
12. Nash M.M., and Zaltzman J.S. Efficacy of azithromycin in the treatment of cyclosporin-induced gingival hyperplasia among renal transplant recipients. Transplant Proc 30 (1998) 2117
13. Argani H., Pourabbas R., and Hassanzadeh D. Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste. Exp Clin Transplant 4 (2006) 420
14. Spolidorio L.C., Holzhausen M., Spolidorio D.M.P., et al. Cyclosporin but not tacrolimus significantly increases salivary cytokine contents in rats. J Periodontol 76 (2005) 1520
15. Wrigth H.J., Chapple I.L.C., and Matthews J.B. TGF-β isoforms and TGF-β receptors in drug-induced gingival and hereditary gingival overgrowth. J Oral Pathol 30 (2001) 281
16. Attisano L., and Wrana J.L. Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev 7 (1996) 327
17. Massgue J. The transforming growth factor-β family. Annu Rev Cell Biol 6 (1990) 597
18. Tone A., Shikata K., Sasaki M., et al. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia 48 (2005) 2402